Vietnam Insulin Drug And Delivery Device Market Share

Statistics for the 2023 & 2024 Vietnam Insulin Drug And Delivery Device market share, created by Mordor Intelligence™ Industry Reports. Vietnam Insulin Drug And Delivery Device share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Vietnam Insulin Drug And Delivery Device Industry

The market is highly consolidated, with three major manufacturers holding a global market presence and the remaining manufacturers confined to other local or region-specific manufacturers. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have the alliance to develop and commercialize Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

Vietnam Insulin Drug And Delivery Device Market Leaders

  1. Novo Nordisk

  2. Sanofi

  3. Eli Lilly

  4. Medtronics

  5. Roche

*Disclaimer: Major Players sorted in no particular order

Vietnam Insulin Drug And Delivery Device Market Concentration

Vietnam Insulin Drug And Delivery Device Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)